Desidustat

The trial will also evaluate Key Secondary Endpoints including Mean change in haemoglobin, the proportion of patients requiring…

Zydus Lifesciences recently entered into a co-marketing partnership with Sun Pharma for desidustat for anemia associated with CKD…

The drug will be marketed by Sun Pharma under the brand name RYTSTAT. Zydus continues to market the drug under the brand name…

Oxemia (Desidustat) is a prescription drug approved in India for patients with Chronic Kidney Disease (CKD)-induced anaemia, and…

OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…

Zydus Cadila has recently filed desidustat in India based on Dream-ND (588 patients) and Dream-D (392 patients) phase-III trials'…

The company submits first New Drug Application (NDA) to DCGI

None of the hospitalised patients required mechanical ventilator in the Desidustat arm, while 25 per cent patients on the standard…

Desidustat is a novel drug which is also currently undergoing phase-III trials for treating anemia in chronic kidney disease…

As a part of the study, 100 mg tablets of Desidustat will be administered for a period of 14 days along with recommended standard…